Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 Feb 22:15:13.
doi: 10.1186/s12877-015-0010-7.

Improving end-of-life care in acute geriatric hospital wards using the Care Programme for the Last Days of Life: study protocol for a phase 3 cluster randomized controlled trial

Rebecca Verhofstede  1 , Tinne Smets  2 , Joachim Cohen  3 , Massimo Costantini  4 , Nele Van Den Noortgate  5 , Luc Deliens  6   7
Affiliations
Clinical Trial

Improving end-of-life care in acute geriatric hospital wards using the Care Programme for the Last Days of Life: study protocol for a phase 3 cluster randomized controlled trial

Rebecca Verhofstede et al. BMC Geriatr. .

Abstract

Background: The Care Programme for the Last Days of Life has been developed to improve the quality of end-of-life care in acute geriatric hospital wards. The programme is based on existing end-of-life care programmes but modeled to the acute geriatric care setting. There is a lack of evidence of the effectiveness of end-of-life care programmes and the effects that may be achieved in patients dying in an acute geriatric hospital setting are unknown. The aim of this paper is to describe the research protocol of a cluster randomized controlled trial to evaluate the effects of the Care Programme for the Last Days of Life.

Methods and design: A cluster randomized controlled trial will be conducted. Ten hospitals with one or more acute geriatric wards will conduct a one-year baseline assessment during which care will be provided as usual. For each patient dying in the ward, a questionnaire will be filled in by a nurse, a physician and a family carer. At the end of the baseline assessment hospitals will be randomized to receive intervention (implementation of the Care Programme) or no intervention. Subsequently, the Care Programme will be implemented in the intervention hospitals over a six-month period. A one-year post-intervention assessment will be performed immediately after the baseline assessment in the control hospitals and after the implementation period in the intervention hospitals. Primary outcomes are symptom frequency and symptom burden of patients in the last 48 hours of life.

Discussion: This will be the first cluster randomized controlled trial to evaluate the effect of the Care Programme for the Last Days of Life for the acute geriatric hospital setting. The results will enable us to evaluate whether implementation of the Care Programme has positive effects on end-of-life care during the last days of life in this patient population and which components of the Care Programme contribute to improving the quality of end-of-life care.

Trial registration: ClinicalTrials.gov Identifier: NCT01890239. Registered June 24th, 2013.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The Care programme for the last days of life. 1A multi-professional document that provides a template of care for the last days and hours of life with recommendations on different aspects of care and guidance for the psychological and spiritual support of patients and their families. 2This guide assists health care staff in implementing the Care Programme for the Last Days of Life on the geriatric ward during a six-month period.
Figure 2
Figure 2
Flowchart of the cluster randomized controlled trial.
See this image and copyright information in PMC

References

    1. Morrison RS, Meier DE. Palliative care. N Engl J Med. 2004;350(25):2582–2590. doi: 10.1056/NEJMcp035232. - DOI - PubMed
    1. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326:30–34. doi: 10.1136/bmj.326.7379.30. - DOI - PMC - PubMed
    1. Bradley E, Cramer L, Bogardus JST, Kasl SV, Johnson-Hurzeler R, Horwitz SM. Physicians’ ratings of their knowledge, attitudes, and End-of-life-care practices. Acad Med. 2002;77(4):305–311. doi: 10.1097/00001888-200204000-00009. - DOI - PubMed
    1. Sullivan A, Lakoma MD, Block SD. The status of medical education in End-of-life care. J Gen Intern Med. 2003;18(9):685–695. doi: 10.1046/j.1525-1497.2003.21215.x. - DOI - PMC - PubMed
    1. Curtis JR, Patrick DL, Caldwell ES, Collier AC. Why don’t patients and physicians talk about end-of-life care?: Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med. 2000;160(11):1690–1696. doi: 10.1001/archinte.160.11.1690. - DOI - PubMed

Publication types

Associated data

LinkOut - more resources